Derma Sciences Inc  

(Public, NASDAQ:DSCI)   Watch this stock  
Find more results for DSCI
+0.09 (2.02%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.20 - 4.62
52 week 3.85 - 9.89
Open 4.43
Vol / Avg. 0.00/335,751.00
Mkt cap 117.16M
P/E     -
Div/yield     -
EPS -1.50
Shares 25.81M
Beta 0.96
Inst. own 83%
Dec 2, 2015
Derma Sciences Inc at Piper Jaffray Healthcare Conference - 9:00AM EST - Add to calendar
Nov 19, 2015
Derma Sciences Inc at Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 12, 2015
Derma Sciences Inc Business Update Call - Webcast
Nov 9, 2015
Q3 2015 Derma Sciences Inc Earnings Call - Webcast
Nov 9, 2015
Q3 2015 Derma Sciences Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -40.43% -47.49%
Operating margin -42.02% -47.89%
EBITD margin - -43.18%
Return on average assets -29.79% -34.91%
Return on average equity -33.48% -39.24%
Employees 299 -
CDP Score - -


214 Carnegie Ctr Ste 300
PRINCETON, NJ 08540-6237
United States - Map
+1-609-5144744 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Derma Sciences, Inc. (Derma Sciences) is a tissue regeneration company, which is engaged in the research and management of acute and chronic wounds, and burns. The Company operates through three segments: pharmaceutical wound care, advanced wound care and traditional wound care products. Pharmaceutical wound care products consist of DSC127, a product for the treatment of a variety of dermal applications, including diabetic foot ulcers and scar prevention. DSC127 for diabetic foot ulcers is in Phase III of clinical development and in pre-clinical stage of scar prevention. Advanced wound care products consist of differentiated dressings, bandages and ointments for wound healing and/or prevent infection, including MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closer strips, catheter fasteners and skin care products.

Officers and directors

Edward J. Quilty Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
John E. Yetter CPA Chief Financial Officer, Executive Vice President - Finance
Age: 62
Bio & Compensation  - Reuters
Robert C. Cole Group President - Traditional Wound Care and Corporate Accounts
Age: 62
Bio & Compensation  - Reuters
Barry J. Wolfenson Group President- Advanced Wound Care
Age: 48
Bio & Compensation  - Reuters
Frederic Eigner Executive Vice President - Operations; General Manager of Derma Sciences Canada, Inc.
Age: 65
Bio & Compensation  - Reuters
Bruce F. Wesson Vice Independent Lead Director
Age: 72
Bio & Compensation  - Reuters
Stephen T. Wills CPA Lead Independent Director
Age: 58
Bio & Compensation  - Reuters
Brett Donald Hewlett Director
Age: 52
Bio & Compensation  - Reuters
Srini Conjeevaram Independent Director
Age: 56
Bio & Compensation  - Reuters
Robert G. Moussa Independent Director
Age: 67
Bio & Compensation  - Reuters